·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¤°í¹®ÀÇ
µ¶ÀÚÁ¦º¸
Event
´º½º
Àüü±â»ç
Á¤Ã¥ · ¹ý·ü
Á¦¾à · ¹ÙÀÌ¿À
¾à±¹ · º´¿ø
Ä«µå´º½º
ÆÊTV
À̽´¿µ»ó
ºÎÀۿ븮Æ÷Æ®
1µî ¾à±¹À» ã¾Æ¼
½ºÆ¿ÄÆ ¿µ»ó
¿ÀÇǴϾð
Àü¹®°¡Ä®·³
µ¥½ºÅ©½Ã¼±
±âÀÚÀÇ ´«
µ¶ÀÚ±â°í
English
Policy
Opinion
Company
Product
Interview
TVÆÊµµ¶ó
ÆÊTube
ÆÊ¼îÇÎ
³ª´Â¾à»ç´Ù
ÆÊµå¶ó¸¶
ÆÊ¾ÆÄ«µ¥¹Ì
Á¦Ç°°ÁÂ
Çмú°ÁÂ
°æ¿µ°ÁÂ
Ä¿¹Â´ÏƼ
ÆÊ¸®Äí¸£Æ®
ä¿ëÁ¤º¸
PHARMARCY
ÀÎÀçÁ¤º¸
DPºÎµ¿»ê
¾à±¹»ó´ã¼Ò
¾à±¹´ëÃâ
¼¼¹«»ó´ã
¹ý·ü»ó´ã
¾à±¹ÈÀåǰ
¾à±¹°æ¿µ
¾à»ç´ëÃâ
ÀǾàÀÚ·á½Ç
ÀǾàÇàÁ¤
¾à»ç¾à±¹
ÀǷẴ¿ø
Á¦¾àÀ¯Åë
º¸µµÀÚ·á
ÆÊÆ÷ÀÎÆ®¸ô
À¯¸Ó · ¸¸È
ÀÎ»ç · ºÎÀ½
¾à±¹ÀåÅÍ
ȸ»ç¼Ò°³
ȸ¿ø°¡ÀÔ
±¤°í¹®ÀÇ
»ç¾÷Á¦ÈÞ
ÀÎÅͳݽŹ®À±¸®°·É
µ¶ÀÚÁ¦º¸
±âÀÚÀ±¸®°·É
ÀÚÀ²¼¾à¼
¿ø°ÝÁö¿ø¿äû
Event & ¼¼¹Ì³ª
Àüü±â»ç
±×·¡ÇÈ
Á¤Ã¥¡¤¹ý·ü
Á¦¾à¡¤¹ÙÀÌ¿À
¾à±¹¡¤º´¿ø
±âȹ¡¤Å½»ç
»ç¼³
Àü¹®°¡Ä®·³
µ¥½ºÅ©½Ã¼±
񃯇
񃯇
ÀǾàǰ
³¹¾Ë½Äº°
µ¥Àϸ®ÆÊ Live Search
´Ý±â
´º½º
>
Á¦¾à¹ÙÀÌ¿À
>
R&D¿Í ¾à¹°
Æ®·Îµ¨ºñ, »ïÁßÀ½¼ºÀ¯¹æ¾Ï 2Â÷ Ç¥ÁØÄ¡·áÁ¦·Î µî±ØÇÒ±î
2023-11-07 17:19:07
[µ¥Àϸ®ÆÊ=¼ÕÇü¹Î ±âÀÚ] Ç×ü¾à¹°Á¢ÇÕü(Antibody Drug Conjugate, ADC) Ç×¾ÏÁ¦°¡ ±¹³» »ïÁßÀ½¼ºÀ¯¹æ¾Ï Ä¡·á ½ÃÀå¿¡ óÀ½ µîÀåÇß´Ù. ÇöÀç±îÁö´Â ¸é¿ªÇ×¾ÏÁ¦¿Í PARP...
¼ÕÇü¹Î ±âÀÚ
GIFT 1È£ '·é¼ö¹Ì¿À' Çã°¡¿Í µ¿½Ã¿¡ ±Þ¿© ½É»ç µ¹ÀÔ
2023-11-07 05:50:42
[µ¥Àϸ®ÆÊ=¾îÀ±È£ ±âÀÚ] ¸²ÇÁÁ¾ ½Å¾à ·é¼ö¹Ì¿À°¡ ±¹³» Çã°¡¿Í ÇÔ²² °ð¹Ù·Î º¸Çè±Þ¿© ½É»ç¿¡ µ¹ÀÔÇÑ´Ù. °ü·Ã ¾÷°è¿¡ µû¸£¸é Çѱ¹·Î½´ÀÇ CD20xCD3 ÀÌÁß Æ¯ÀÌÇ×ü ·é¼ö...
¾îÀ±È£ ±âÀÚ
'ÀÓ»ó½ÇÆÐ ¾à¹° ÀçȰ¿ë'...AZ, ½ÅÀå º´¿ë¿ä¹ý¼ È¿°ú È®ÀÎ
2023-11-07 05:50:30
[µ¥Àϸ®ÆÊ=¼ÕÇü¹Î ±âÀÚ] ¾Æ½ºÆ®¶óÁ¦³×Ä«°¡ SGLT-2 ¾ïÁ¦Á¦ °è¿ ´ç´¢º´ Ä¡·áÁ¦ Æ÷½Ã°¡(´ÙÆÄ±Û¸®Ç÷ÎÁø)¿Í °ú°Å Ç×¾ÏÁ¦·Î °³¹ßÇß´ø Áöº¸ÅÙźÀ» º´¿ëÇØ ¸¸¼º½ÅÀåÁúȯ(CKD)...
¼ÕÇü¹Î ±âÀÚ
´ç´¢¡¤ºñ¸¸ ÀÌ¾î ½ÅÀåÁúȯµµ È¿°ú...ÁøÈÇÏ´Â GLP-1 ½Å¾à
2023-11-06 12:10:53
[µ¥Àϸ®ÆÊ=¼ÕÇü¹Î ±âÀÚ] ´ç´¢º´ Ä¡·áÁ¦·Î Çã°¡¹ÞÀº GLP-1 ¼ö¿ëü ÀÛ¿ëÁ¦(ÀÌÇÏ GLP-1 Á¦Á¦)°¡ ºñ¸¸°ú ½ÅÀåÁúȯ »Ó ¾Æ´Ï¶ó ºñ¾ËÄڿüºÁö¹æ°£¿°(NASH), Ä¡¸Å µîÀ¸·Î ¿µ¿ª ...
¼ÕÇü¹Î ±âÀÚ
Áö¾ÆÀÌÀ̳뺣À̼Ç, ¸é¿ªÇ×¾ÏÇÐȸ¼ ºòÆÄ¸¶¿Í ±â¼úÀÌÀü ³íÀÇ
2023-11-06 10:00:05
[µ¥Àϸ®ÆÊ=³ëº´Ã¶ ±âÀÚ] Áö¾ÆÀÌÀ̳뺣À̼ÇÀº ¹Ì±¹ ¸é¿ªÇ×¾ÏÇÐȸ(Society for Immunotherapy of Cancer 2023, ÀÌÇÏ SITC 2023)¿¡¼ ¡®¸é¿ªÇ×¾ÏÁ¦ ³»¼º ±Øº¹¡¯ °¡´É¼º...
³ëº´Ã¶ ±âÀÚ
ÀûÀÀÁõ ¹Ù²ã ÀçµµÀüÇÑ 'Æú¶óÀ̺ñ' ¾ÏÁú½É »óÁ¤ Ã˰¢
2023-11-06 05:50:42
[µ¥Àϸ®ÆÊ=¾îÀ±È£ ±âÀÚ] 1Â÷¿ä¹ýÀ¸·Î ÀûÀÀÁõÀ» ¹Ù²ã µµÀüÇÏ´Â Ç÷¾×¾ÏÄ¡·áÁ¦ Æú¶óÀ̺ñÀÇ º¸Çè±Þ¿© µîÀç ³íÀÇ¿¡ ÁøÀüÀÌ »ý±æÁö ÁÖ¸ñµÈ´Ù. °ü·Ã ¾÷°è¿¡ µû¸£¸é Çѱ¹·Î...
¾îÀ±È£ ±âÀÚ
±Û·Î¹ú Á¦¾à mRNA Ȱ¿ë ±Ø´ëÈ...¾Ï ¹é½Å °³¹ß Ȱ¹ß
2023-11-04 05:50:55
[µ¥Àϸ®ÆÊ=¼ÕÇü¹Î ±âÀÚ] Äڷγª19 ¸Þ½ÅÀú¸®º¸ÇÙ»ê(mRNA) ¹é½Å °³¹ß¿¡ ¼º°øÇÑ ±Û·Î¹ú Á¦¾à»çµéÀÇ ´ÙÀ½ Ÿ±êÀº ¾ÏÀÌ´Ù. °³¹ß ÁßÀÎ mRNA ¾Ï ¹é½ÅÀº ¿¹¹æ ¸ñÀûº¸´Ù´Â ¾Ïȯ...
¼ÕÇü¹Î ±âÀÚ
°æº¸Á¦¾à ÁøÅëÁÖ»ç ¸Æ½ÃÁ¦½Ä, FDA ½Å¾à Çã°¡
2023-11-03 15:25:34
[µ¥Àϸ®ÆÊ=³ëº´Ã¶ ±âÀÚ] °æº¸Á¦¾à(´ëÇ¥ ±èÅ¿µ)Àº ±¹³»¿¡¼ µ¶Á¡ ÆÇ¸Å ÁßÀÎ ºñ¸¶¾à¼º ÁøÅë º¹ÇÕÁÖ»çÁ¦ ¡®¸Æ½ÃÁ¦½Ä(ÁÖ¼ººÐ¾Æ¼¼Æ®¾Æ¹Ì³ëÆæ/À̺ÎÇÁ·ÎÆæ)¡¯ÀÌ ¹Ì±¹ ½Äǰ...
³ëº´Ã¶ ±âÀÚ
º¸³ëÇÁ¶óÀÜ, ºÒ¼ø¹° ¾ÈÀü¼º È®º¸...¹Ì P-CAB ½ÃÀå °³¸·
2023-11-03 05:50:41
[µ¥Àϸ®ÆÊ=¼ÕÇü¹Î ±âÀÚ] ¹Ì±¹ ¹ÙÀÌ¿À ±â¾÷ÀÌ º¸³ëÇÁ¶óÀÜÀÇ ºÒ¼ø¹° ¹®Á¦¸¦ ÇØ°áÇÏ¸é¼ Ä®·ý °æÀïÀû À§»ê ºÐºñ ¾ïÁ¦Á¦(P-CAB)ÀÇ ºÏ¹Ì ½ÃÀå °³¸·ÀÌ ÀÓ¹ÚÇß´Ù. ±¹³» ±â¾÷...
¼ÕÇü¹Î ±âÀÚ
SMAÄ¡·áÁ¦ '½ºÇɶóÀÚ' ±Þ¿© È®´ë..."°æÀï¾à¹°°ú Â÷º°È"
2023-11-02 13:09:41
[µ¥Àϸ®ÆÊ=¼ÕÇü¹Î ±âÀÚ] ô¼ö° ³» Á÷Á¢Åõ¿©, ´Ùȸ Åõ¿©°¡ °¡´ÉÇÏ´Ù´Â ÀåÁ¡À» °¡Áø ô¼ö±ÙÀ§ÃàÁõ(Spinal Muscular Atrophy, SMA) Ä¡·áÁ¦ ¹ÙÀÌ¿ÀÁ¨ÀÇ ½ºÇɶóÀÚ°¡ ¿¬·ÉÁ¦...
¼ÕÇü¹Î ±âÀÚ
1
2
3
4
5
6
7
8
9
10
>
ä¿ë
¼Óº¸
ÆÊ¼îÇθô
ÀǾàǰ¸ô
Çコ¿ëǰ¸ô
±âŸ»óǰ¸ô
Àϼº½Å¾à
¸ÞµðÄ«ÄÚ¸®¾Æ
¿¥¿¡ÇÁ¾¾
À¯´Ï¸Þµå
¶ó¿ÂÆÄ¸¶
Çdzª¿ÂÁ¤
¸ÞµðÄ«ÄÚ¸®¾Æ
ÃÊÀÓ°è¾ËƼÁö
À¯´Ï¸ÞµåÁ¦¾à
À¯´Ï¼¾Å¸¾×
Àϼº½Å¾à
ÇÃ·ç¾ÆµåÄõµå
À¯´Ï¸ÞµåÁ¦¾à
¸ÞµðÆÊ¸ô
¸ÞµðÄ®Çö´ë
¸¶´õ½ºÁ¦¾à
´õÆÊ¾ÆÀÌÁ¶¾Æ
ưưŰÁî
¿¥¿¡ÇÁ¾¾
¾Æ·Î´Ï¾Æ´Ü¹éÁú¹Ù
¼¿·ÐÅØ
Èĸ¨
À¯´Ï¸ÞµåÁ¦¾à
À¯´Ïµ§Å»¿ÃÄɾîÄ¡¾à
¸¶´õ½ºÁ¦¾à
ÄÜÆ¼600
ÈÞº£À̽º
KnH¸ÞµðÅØ
°æ¹æ½Å¾à
¸Þµð¶óÀÌÇÁ
ÂøÇѳª¹«ÀÎÅ׸®¾î
³»¼Õ¾ÈÀÇ ¾à±¹
´ÚÅÍ¾ØÆÊ
µ¿ÀÇÇѹæ
µ¿ÀÇÇѹæÃ¼ÀÎ
°æ¹æ½Å¾à
°æ¿Á°í
¾à»ç ½Å¿ë´ëÃâ
¾à±¹ÀÎÅ׸®¾î
¾à»ç´Ô ÀÔ¼Ò¹®
¾à»ç¸¦ À§ÇÑ ¾à±¹ Ç÷§Æû
¿¥¿¡ÇÁ¾¾
¿¥Å©¸°
¾à±¹°æ¿µ¼¼¹Ì³ª ÈÞº£À̽º
¾Ë¸² ¡¤ °øÇ¥
±³À° ¡¤ °ÁÂ
¾à±¹»ó´ã¼Ò
Á¢¼ö ¡¤ ¹®ÀÇ
¾Ë¸²
[3RÄÚ¸®¾Æ]ICT ±ÔÁ¦»÷µå¹Ú½º ½ÇÁõ Ư·Ê ½ÂÀÎ!! ¼³Ä¡ ¹× ...
¾Ë¸²
¶ó¿ÂÆÄ¸¶,Å»¸ðº¸Á¶Á¦ ÆÇ½Ã¿Âĸ½¶ Ãâ½Ã!
¾Ë¸²
Á¦ 5ȸ ´ÚÅÍ¾ØÆÊ Ã¢¾÷¼¼¹Ì³ª 11.26(ÀÏ) ½Åû GO¢º
¾Ë¸²
ºñŸºñÄɾîÁ¤ ½ÅÁ¦Ç° Ãâ½Ã EVENT! Go¢º
¾Ë¸²
[TVÆÊµµ¶ó]¾çÄ¡¿Í ÀÕ¸öÁúȯ Ä¡·á±îÁö Çѹø¿¡!
¾Ë¸²
½ºÆ®·¾½Ç ½Å±Ô 📺TV±¤°í ·Ðαâ³ä EVENT¢º
D-25
[ÆÊŬ·¡½º]Àü°Á ¹«Á¦ÇÑ ½Ãû! (Ç×½ÃÁ¢¼ö) ( ~12.31 )
D-25
[ÆÊ½ºÅ͵ð]ij³ª´Ù ¾à»ç ÀÚ°ÝÁõ[Ç×½ÃÁ¢¼ö] ( ~12.31 )
¼¼¹«»ó´ã
¾à±¹¾çµµ¾ç¼ö½Ã ÀÏ¹Ý¾à °è»ê?
¾à±¹ÈÀåǰ
ư»ìÅ©¸² ¹®ÀÇ
¾à»ç½Å¿ë´ëÃâ
°³±¹¾à»çÀÔ´Ï´Ù
ÆùºÎ½º´ëºÎ
3°³ ¾à±¹¿¡ ÀçÁ÷ ÁßÀÎ ±Ù¹« ¾à»ç ´ëÃâ ¹®ÀÇ
¾à»ç´ëÃâ
ºÀÁ÷¾à»ç ´ëÃâ ÈÄ ÅðÁ÷½Ã
¾à±¹°æ¿µ°ú â¾÷
Ãþ¾à±¹¿¡¼ ¸Å¾àÀº ¾ó¸¶±îÁö °¡´ÉÇѰ¡¿ä?
¹ý·ü»ó´ã
ƯÁ¤¾à±¹ °¡Áö¸»¶ó´Â ¸»À» ÇÕ´Ï´Ù
¼¼¹«¡¤³ë¹«
±Ù·Î°è¾à¼ ÀÛ¼ºÇÏÁö ¾ÊÀº ÀÏ¿ëÁ÷±Ù·ÎÀÚ
±³À° °Á ¹× ¾Ë¸² ±¤°í ¾È³» ÆäÀÌÁö
¿¬¼ö, ±³À°, ¼¼¹Ì³ª, Çмú°Á ¹× ±â¾÷±³À°, ¸ðÁý
°øÇ¥, Åä·Ðȸ, ÀǾàǰ º¯°æ ¾È³» ¹× °¢Á¾ Çà»ç
¾Ë¸² ±¤°í¸¦ ÇØµå¸³´Ï´Ù.
(Á¢¼ö ¹®ÀÇ ¹Ù·Î°¡±â)
¿À´ÃÀÇ
ÇÖ´º½º
1
¾ß°£¡¤ÈÞÀÏ ºñ´ë¸é ÃÊÁø Àü¸é Çã¿ë...°³¿ø°¡ Âü¿©°¡ °ü°Ç
2
»ç¾÷ ´Ù°¢È¿Í ij½ÃÄ«¿ì È®º¸...Á¦¾à¾÷°è »õ M&A dz¼Óµµ
3
¿ÃÇØ ±Û·Î¹úÁ¦¾à M&A Ű¿öµå 'ADC¡¤ºñ¸¸¡¤Èñ±ÍÁúȯ'
4
À¯È¿±â°£ ³¡³ ÀÚÁøÃë¼Ò ¾à, ¾ðÁ¦±îÁö À¯Åë °¡´ÉÇÒ±î
5
󹿱îÁö ³Ñº¸´Â ÇѾà»çµé...Á¶Á¦¾à±¹ Àμö ³í¶õ
6
"Æó¾Ï Á¤º¹ ´«ºÎ½Å ¹ßÀü...ÃʱâÄ¡·á ¿µ¿ª È®Àå ±â´ë°¨"
7
ȮǮ¸° ºñ´ë¸é ¿µÇâ ¹ý°³Á¤ ¹«»ê¡¦22´ë ±¹È¸ ¼ÓµµÀü
8
[±âÀÚÀÇ ´«] Äڷγª19, ¿£µ¥¹ÍÀº '³¡'ÀÌ ¾Æ´Ï´Ù
9
[µ¥½ºÅ©½Ã¼±] Åå½ÅÀÇ ¹ß°ß°ú Àηù°ø¿µ
10
¼ö±ÞºÒ¾ÈÁ¤ ¾àÁ¦, Á¶Á¤Çù»óµµ ¸í½Ã¡¦»çÀüÇùÀÇ¡¤°¡»ê